Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Topical
Solubilizers
Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
81
PharmaCompass offers a list of Carboprost Tromethamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carboprost Tromethamine manufacturer or Carboprost Tromethamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carboprost Tromethamine manufacturer or Carboprost Tromethamine supplier.
PharmaCompass also assists you with knowing the Carboprost Tromethamine API Price utilized in the formulation of products. Carboprost Tromethamine API Price is not always fixed or binding as the Carboprost Tromethamine Price is obtained through a variety of data sources. The Carboprost Tromethamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Carboprost manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carboprost, including repackagers and relabelers. The FDA regulates Carboprost manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carboprost API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Carboprost manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Carboprost supplier is an individual or a company that provides Carboprost active pharmaceutical ingredient (API) or Carboprost finished formulations upon request. The Carboprost suppliers may include Carboprost API manufacturers, exporters, distributors and traders.
click here to find a list of Carboprost suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Carboprost DMF (Drug Master File) is a document detailing the whole manufacturing process of Carboprost active pharmaceutical ingredient (API) in detail. Different forms of Carboprost DMFs exist exist since differing nations have different regulations, such as Carboprost USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Carboprost DMF submitted to regulatory agencies in the US is known as a USDMF. Carboprost USDMF includes data on Carboprost's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Carboprost USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Carboprost suppliers with USDMF on PharmaCompass.
A Carboprost CEP of the European Pharmacopoeia monograph is often referred to as a Carboprost Certificate of Suitability (COS). The purpose of a Carboprost CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Carboprost EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Carboprost to their clients by showing that a Carboprost CEP has been issued for it. The manufacturer submits a Carboprost CEP (COS) as part of the market authorization procedure, and it takes on the role of a Carboprost CEP holder for the record. Additionally, the data presented in the Carboprost CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Carboprost DMF.
A Carboprost CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Carboprost CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Carboprost suppliers with CEP (COS) on PharmaCompass.
A Carboprost written confirmation (Carboprost WC) is an official document issued by a regulatory agency to a Carboprost manufacturer, verifying that the manufacturing facility of a Carboprost active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Carboprost APIs or Carboprost finished pharmaceutical products to another nation, regulatory agencies frequently require a Carboprost WC (written confirmation) as part of the regulatory process.
click here to find a list of Carboprost suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Carboprost as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Carboprost API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Carboprost as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Carboprost and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Carboprost NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Carboprost suppliers with NDC on PharmaCompass.
Carboprost Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Carboprost GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Carboprost GMP manufacturer or Carboprost GMP API supplier for your needs.
A Carboprost CoA (Certificate of Analysis) is a formal document that attests to Carboprost's compliance with Carboprost specifications and serves as a tool for batch-level quality control.
Carboprost CoA mostly includes findings from lab analyses of a specific batch. For each Carboprost CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Carboprost may be tested according to a variety of international standards, such as European Pharmacopoeia (Carboprost EP), Carboprost JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Carboprost USP).
